GAMMA Investing’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.3K Buy
1,607
+1,093
+213% +$12.9K ﹤0.01% 2964
2026
Q2
$5.5K Buy
514
+208
+68% +$1.61K ﹤0.01% 3425
2026
Q1
$1.95K Buy
306
+108
+55% +$752 ﹤0.01% 3673
2025
Q4
$1.39K Buy
198
+86
+77% +$519 ﹤0.01% 3705
2025
Q3
$616 Buy
112
+67
+149% +$328 ﹤0.01% 3690
2025
Q2
$233 Sell
45
-340
-88% -$2.04K ﹤0.01% 3710
2025
Q1
$2.56K Buy
385
+305
+381% +$2.32K ﹤0.01% 3339
2024
Q4
$590 Buy
80
+37
+86% +$266 ﹤0.01% 3543
2024
Q3
$301 Sell
43
-61
-59% -$367 ﹤0.01% 3454
2024
Q2
$511 Buy
104
+78
+300% +$470 ﹤0.01% 3203
2024
Q1
$160 Buy
26
+24
+1,200% +$162 ﹤0.01% 3252
2023
Q4
$12 Buy
+2
New +$13 ﹤0.01% 3180

Other funds holding LFST

GAMMA Investing's LFST Position: Q3 2026 in Review

GAMMA Investing increased its Lifestance Health (LFST) stake by 213% in Q3 2026, buying an estimated $12.9K and bringing the position to 1,607 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2964.

GAMMA Investing first reported a position in LFST in Q4 2023 and has held it in 12 quarters since. 15 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

  • GAMMA Investing held 1,607 shares of Lifestance Health worth $19.3K as of Q3 2026.
  • GAMMA Investing bought 1,093 Lifestance Health shares in Q3 2026, an estimated $12.9K.
  • Lifestance Health made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2964 holding.
  • GAMMA Investing first reported a position in Lifestance Health in Q4 2023 and has held it in 12 quarters since.
  • 15 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.